Maccura Biotechnology Co Ltd Cash Flow Conversion Efficiency
Maccura Biotechnology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Maccura Biotechnology Co Ltd (300463) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥148.82 Million ≈ $21.78 Million USD) by net assets (CN¥6.38 Billion ≈ $933.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Maccura Biotechnology Co Ltd (2011–2025)
Cash flow conversion efficiency of Maccura Biotechnology Co Ltd from 2011 to 2025. This chart illustrates how Maccura Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Maccura Biotechnology Co Ltd stock price for real-time trading data and today's change.
Maccura Biotechnology Co Ltd Cash Flow Conversion Ratio Explained
Maccura Biotechnology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Maccura Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Maccura Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Also see Maccura Biotechnology Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xinjiang Qingsong Building Materials and Chemicals Group Co Ltd
SHG:600425
|
0.028x |
|
Lushang Property Co Ltd
SHG:600223
|
0.004x |
|
Wutong Holding Group Co Ltd
SHE:300292
|
-0.004x |
|
MAHLE Metal Leve S.A
SA:LEVE3
|
0.181x |
|
X Fab Silicon Foundries EV
PA:XFAB
|
-0.004x |
|
Precision Wires India Limited
NSE:PRECWIRE
|
0.131x |
|
Kelsian Group Ltd
AU:KLS
|
0.087x |
|
Southern Cable Group Bhd
KLSE:0225
|
0.036x |
Annual Cash Flow Conversion Efficiency for Maccura Biotechnology Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Maccura Biotechnology Co Ltd from 2011 to 2025. Review Maccura Biotechnology Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.31 Billion ≈ $922.72 Million |
CN¥602.33 Million ≈ $88.14 Million |
0.096x | -3.19% |
| 2024-12-31 | CN¥6.42 Billion ≈ $939.98 Million |
CN¥633.80 Million ≈ $92.74 Million |
0.099x | -28.48% |
| 2023-12-31 | CN¥6.61 Billion ≈ $967.46 Million |
CN¥912.09 Million ≈ $133.47 Million |
0.138x | +6.83% |
| 2022-12-31 | CN¥6.53 Billion ≈ $955.50 Million |
CN¥843.22 Million ≈ $123.39 Million |
0.129x | -63.72% |
| 2021-12-31 | CN¥4.54 Billion ≈ $664.60 Million |
CN¥1.62 Billion ≈ $236.57 Million |
0.356x | +30.32% |
| 2020-12-31 | CN¥4.01 Billion ≈ $586.12 Million |
CN¥1.09 Billion ≈ $160.09 Million |
0.273x | +97.80% |
| 2019-12-31 | CN¥3.33 Billion ≈ $486.94 Million |
CN¥459.52 Million ≈ $67.24 Million |
0.138x | +104.03% |
| 2018-12-31 | CN¥2.86 Billion ≈ $419.24 Million |
CN¥193.91 Million ≈ $28.37 Million |
0.068x | +123.77% |
| 2017-12-31 | CN¥2.61 Billion ≈ $382.37 Million |
CN¥79.03 Million ≈ $11.57 Million |
0.030x | +40.04% |
| 2016-12-31 | CN¥2.28 Billion ≈ $334.12 Million |
CN¥49.32 Million ≈ $7.22 Million |
0.022x | +30.20% |
| 2015-12-31 | CN¥2.00 Billion ≈ $292.73 Million |
CN¥33.18 Million ≈ $4.86 Million |
0.017x | -88.58% |
| 2014-12-31 | CN¥792.05 Million ≈ $115.90 Million |
CN¥115.09 Million ≈ $16.84 Million |
0.145x | -10.73% |
| 2013-12-31 | CN¥604.48 Million ≈ $88.46 Million |
CN¥98.39 Million ≈ $14.40 Million |
0.163x | -35.02% |
| 2012-12-31 | CN¥442.98 Million ≈ $64.82 Million |
CN¥110.96 Million ≈ $16.24 Million |
0.250x | -8.71% |
| 2011-12-31 | CN¥311.77 Million ≈ $45.62 Million |
CN¥85.55 Million ≈ $12.52 Million |
0.274x | -- |
About Maccura Biotechnology Co Ltd
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such a… Read more